ask="14.90"
ask_size="100"
average_daily_volume="39245"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="-0.20"
change_from_200_day_moving_average="-5.47"
change_from_50_day_moving_average="-3.07"
change_from_52_week_high="-12.89"
change_From_52_week_low="3.45"
change_in_percent="-1.46%"
close="13.47"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="7054000"
high="13.69"
high_52_weeks="26.36"
last_trade_date="3/7/2017"
last_trade_price="13.47"
last_trade_size="1070"
last_trade_time="4:00pm"
low="13.22"
low_52_weeks="10.02"
market_capitalization="225.14M"
moving_average_200_day="18.94"
moving_average_50_day="16.54"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="13.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-28.89%"
percent_change_from_50_day_moving_average="-18.59%"
percent_change_from_52_week_high="-48.90%"
percent_change_from_52_week_low="+34.43%"
previous_close="13.67"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.34"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="9.96"
stock_exchange="NGM"
symbol="PTGX"
volume="19298"
weeks_range_52="10.02 - 26.36"
